{"id":53661,"date":"2023-02-06T23:03:14","date_gmt":"2023-02-06T22:03:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/"},"modified":"2023-02-06T23:03:14","modified_gmt":"2023-02-06T22:03:14","slug":"arcus-biosciences-to-participate-at-upcoming-virtual-investor-events","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/","title":{"rendered":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events"},"content":{"rendered":"
\n

HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events:\n<\/p>\n

<\/a><\/p>\n

\nSVB Securities Virtual Global Biopharma Conference
\n
<\/b>Date:<\/i> Tuesday, February 14th<\/sup>, 2023
\n
Time: <\/i>12:00 p.m. ET
\n
Format: <\/i>Fireside Chat\n<\/p>\n

\nCiti\u2019s 2023 Virtual Oncology Leadership Summit
\n
<\/b>Date: <\/i>Tuesday, February 21, 2023
\n
Time:<\/i> 1:00 p.m. ET
\n
Format:<\/i> Fireside Chat\n<\/p>\n

\nLive webcasts of the fireside chats will be available by visiting the \u201cInvestors & Media\u201d section of the Arcus Biosciences website at www.arcusbio.com<\/a>. Replays of the webcast will be available following the live event.\n<\/p>\n

\nAbout Arcus Biosciences<\/b>\n<\/p>\n

\nArcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has advanced six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and A2a\/A2b receptors) and HIF-2a. For more information about Arcus Biosciences\u2019 clinical and preclinical programs, please visit www.arcusbio.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Inquiries<\/b>
Pia Banerjee
\n
Head of Investor Relations & Strategy
\n
(617) 459-2006
\n
pbanerjee@arcusbio.com<\/a>\n<\/p>\n

\nMedia Inquiries<\/b>
Holli Kolkey
\n
VP of Corporate Communications
\n
(650) 922-1269
\n
hkolkey@arcusbio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events: SVB Securities Virtual Global Biopharma Conference Date: Tuesday, February 14th, 2023 Time: 12:00 p.m. ET Format: Fireside … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53661","6":"format-standard","7":"category-industry"},"yoast_head":"\nArcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events: SVB Securities Virtual Global Biopharma Conference Date: Tuesday, February 14th, 2023 Time: 12:00 p.m. ET Format: Fireside ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T22:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Arcus Biosciences to Participate at Upcoming Virtual Investor Events\",\"datePublished\":\"2023-02-06T22:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/\"},\"wordCount\":258,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005139\\\/en\\\/1705180\\\/21\\\/ARCUS_Logo_RGB_1920x1080.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/\",\"name\":\"Arcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005139\\\/en\\\/1705180\\\/21\\\/ARCUS_Logo_RGB_1920x1080.jpg\",\"datePublished\":\"2023-02-06T22:03:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005139\\\/en\\\/1705180\\\/21\\\/ARCUS_Logo_RGB_1920x1080.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005139\\\/en\\\/1705180\\\/21\\\/ARCUS_Logo_RGB_1920x1080.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arcus Biosciences to Participate at Upcoming Virtual Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend","og_description":"HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events: SVB Securities Virtual Global Biopharma Conference Date: Tuesday, February 14th, 2023 Time: 12:00 p.m. ET Format: Fireside ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-06T22:03:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events","datePublished":"2023-02-06T22:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/"},"wordCount":258,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/","url":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/","name":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg","datePublished":"2023-02-06T22:03:14+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230206005139\/en\/1705180\/21\/ARCUS_Logo_RGB_1920x1080.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arcus-biosciences-to-participate-at-upcoming-virtual-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Arcus Biosciences to Participate at Upcoming Virtual Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53661"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53661\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}